Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then please contact the research committee so that we can disseminate these to the membership. Authors who are BOPA members are in bold.

Manuscripts

Time to adjuvant chemotherapy and overall survival in advanced-stage ovarian cancer patients in England: a population-based retrospective cohort study

L Steventon, S Nicum, K Man, D Dodwell, Z Wang, A Patel, ... Chambers P

ESMO Real World Data and Digital Oncology

2025

Integrating International Consensus Guidelines for Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD) into everyday practice

G Sandhu, J Adattini, EA Gordon, N O’Neill, C Bagnis, AV Boddy, …Chambers P, Morris E

eClinicalMedicine

2025

A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function

G Sandhu, EA Gordon, J Adattini, N O’Neill, P Chambers, DW Johnson, …

eClinicalMedicine

2025

Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anticancer therapy (SACT)

J McLean, P Chambers, L Steventon, S Cruickshank, S Nabhani-Gebara

BMJ Quality & Safety

2025

Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review

GA Alarcón Garavito, K Gilchrist, C Ciurtin, S Khanna, P Chambers, …

Trials 26 (1), 65

 

Editorials
Shaping the UK’s long term relationship with tirzepatide

Peter Robertson, Nicholas Browne

BMJ 2025;388:r394  doi: https://doi.org/10.1136/bmj.r394
(Peter is a BOPA CPCP Subcommittee member)

 

 

Latest News

By Mohammed Patel on 11th November 2026

UK BMT Pharmacists Group Educational Meeting – Friday 13th November 2026. Time:14:00 to 16:00

The next UK BMT Pharmacists Group Educational Meeting is on Friday 13th November, 2pm–4pm. The sessions include: Maintenance Therapy for AML After Allogeneic BMT with Dr Mili Shah, Consultant Haematologist,…

Read article
By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article